Beyond Air™

Contributing Author

Recent Articles by Beyond Air™

Jun-22	Beyond Air Schedules Fiscal Year End 2026 Financial Results Conference Call and Webcast XAIR +14.43% XAIR +13.61% GlobeNewswire
Jun-10	Beyond Air, Inc. Urges Stockholders to Vote "FOR" All Proposals Ahead of the Upcoming Special Meeting XAIR GlobeNewswire
Jun-01	Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing XAIR +5.70% GlobeNewswire
Apr-20	Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026 XAIR GlobeNewswire
Apr-15	Beyond Air to Participate in the D. Boral Capital Global Conference 2026 XAIR -11.58% GlobeNewswire
Apr-01	Beyond Air Expands Commercial Access for LungFit PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO) XAIR GlobeNewswire
Mar-26	Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO XAIR -6.74% GlobeNewswire
Mar-17	Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial XAIR GlobeNewswire
Mar-11	Beyond Air to Participate in the 38th Annual Roth Conference in March XAIR GlobeNewswire
Mar-10	Beyond Air Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd. XAIR GlobeNewswire
Feb-20	Beyond Air Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections XAIR -7.34% GlobeNewswire
Feb-13	Beyond Air Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update XAIR GlobeNewswire
Feb-04	Beyond Cancer Abstract Featuring Phase 1 Data on Intratumoral Ultra-High Concentration Nitric Oxide (UNO) in Solid Tumor Metastases to be Presented at the AACR Annual Meeting 2026 XAIR -5.22% GlobeNewswire
Jan-27	Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences XAIR -7.53% XAIR -5.93% GlobeNewswire
Jan-26	Beyond Air Schedules Third Fiscal Quarter 2026 Financial Results Conference Call and Webcast XAIR -9.88% GlobeNewswire
Jan-14	Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules XAIR -14.16% GlobeNewswire
Jan-13	XTL Biopharmaceuticals Acquires 85% of Beyond Air's Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership XAIR +150.00% GlobeNewswire
Dec-30	Beyond Air Appoints Dan Moorhead as Chief Financial Officer XAIR GlobeNewswire
Dec-17	Beyond Air Signs New International LungFit PH Distribution Agreements, Most Notably in Germany and Brazil XAIR GlobeNewswire
Nov-26	Beyond Air Announces Transition of Chief Financial Officer XAIR GlobeNewswire
Nov-10	Beyond Air Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update XAIR -16.09% XAIR GlobeNewswire
Nov-05	Beyond Air Secures Up to $32 Million to Accelerate Growth XAIR GlobeNewswire
Oct-23	Beyond Air Schedules Second Fiscal Quarter 2026 Financial Results Conference Call and Webcast XAIR GlobeNewswire
Sep-22	Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference XAIR +5.38% GlobeNewswire
Sep-08	Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds XAIR +49.77% XAIR -23.26% GlobeNewswire
Sep-08	NeuroNOS Granted FDA Orphan Drug Designation for Glioblastoma, the Most Common and Deadliest Primary Malignant Brain Cancer in Adults XAIR +49.77% GlobeNewswire
Sep-03	Beyond Air to Participate in the H.C. Wainwright 27th Annual Global Investment Conference XAIR GlobeNewswire
Aug-20	Beyond Air Signs New International LungFit PH Distribution Agreements, Most Notably in Japan XAIR -6.55% GlobeNewswire
Aug-12	Beyond Air Reports Fiscal First Quarter 2026 Financial Results and Provides Corporate Update XAIR -22.47% XAIR GlobeNewswire
Jul-25	Beyond Air Schedules First Fiscal Quarter 2026 Financial Results Conference Call and Webcast XAIR GlobeNewswire
Jul-22	Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc. XAIR GlobeNewswire
Jun-17	Beyond Air Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update XAIR +58.69% XAIR -29.02% GlobeNewswire
Jun-16	Beyond Air Submits FDA PMA Supplement for Next Generation LungFit PH XAIR GlobeNewswire
May-20	Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast XAIR GlobeNewswire

Beyond Air™

Recent Articles by Beyond Air™

Upgrade your Finviz experience